An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

Update Il y a 4 ans
Reference: NCT00335374

Woman and Man

Extract

This is a multicenter, 6 months open label safety extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.003 trial


Inclusion criteria

  • Early-Stage Parkinson’s Disease


Links